Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin

References

• Jacobson S.H., Moldéus P. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis. Clinical Nephrology 1994; 42: 189–192
   PubMedGoogle Scholar
• Ross E.A., Koo L.C., Moberly J.B. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. American Journal of Kidney Diseases 1997; 30: 489–494
   PubMedGoogle Scholar
• Martin-Mateo M.C., Del Canto-Jafiez E., Barrero-Martinez M.J. Oxidative stress and enzyme activity in ambulatory renal patients undergoing continuous peritoneal dialysis. Renal Failure 1998; 20: 117–124
   PubMed Web of Science ®Google Scholar
• McGregor S.J., Topley N., Jorres A., Speekenbrink A.B., Gordon A., Gahl G.M., Junor B.J., Briggs J.D., Brock J.H. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney International 1996; 49: 525–533
   PubMed Web of Science ®Google Scholar
• Sach M., Loetscher P., Burger J.A., Knopf H.P., Schollmeyer P., Dobos G.J. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Advances in Peritoneal Dialysis 1995; 11: 19–23
   PubMedGoogle Scholar
• Sach M., Bauermeister K., Burger J.A., Loetscher P., Elsner J., Schollmeyer P., Dobos G.J. Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages. Nephrology Dialysis Transplantation 1997; 12: 315–320
   PubMedGoogle Scholar
• Steinhauer H.B., Brugger U., Atmanspacher R., Lubrich-Birkner I., Schollmeyer P. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. Advances in Peritoneal Dialysis 1992; 8: 47–52
   PubMedGoogle Scholar
• Alobaidi H.M., Coles G.A., Davies M., Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrology Dialysis Transplantation 1986; 1: 16–21
   PubMedGoogle Scholar
• de Fijter C.W., Verbrugh H.A., Peters E.D., Oe P.L., van der Meulen J., Verhoef J., Donker A.J. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clinical Nephrology 1993; 39: 75–80
   PubMed Web of Science ®Google Scholar
• Lin C.Y., Ku W.L., Huang T.P. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. American Journal of Nephrology 1990; 10: 368–373
   PubMedGoogle Scholar
• Carcamo C., Fernandez-Castro M., Selgas R., Jimenez C., Molina S., Vara F. Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11b, CD14, CD16, and CD64 on peritoneal macrophages. Peritoneal Dialysis International 1996; 16: 582–589
   PubMedGoogle Scholar
• Täger M., Kröning H., Thiel U., Ansorge S. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Experimental Hematology 1997; 25: 601–607
   PubMed Web of Science ®Google Scholar
• Jiang X.M., Fitzgerald M., Grant C.M., Hogg P.J. Redox control of exofacial protein/disulfides by protein disulfide isomerase. Journal of Biological Chemistry 1999; 247(4)2416–2423
   Google Scholar
• Meister A. Glutathione metabolism. Methods in Enzymology 1995; 251: 3–7
   PubMed Web of Science ®Google Scholar
• Sen C.K. Nutritional biochemistry of cellular glutathione. Journal of Nutritional Biochemistry 1997; 8: 660–672
   Web of Science ®Google Scholar
• Wang W., Ballatori N. Endogenous glutathione conjugates: Occurrence and biological functions. Pharmacological Reviews 1998; 50: 335–355
   PubMed Web of Science ®Google Scholar
• Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.-P., Roth S., Gmünder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB Journal 1994; 8: 1131–1138
   PubMed Web of Science ®Google Scholar
• Fields J.A., Keshavarzian A., Eiznhamer G., Frommel T., Winship D., Holmes E.W. Low levels of blood and colonic glutathione in ulcerative colitis. Gastroenterology 1994; 106: A680–A680
   Google Scholar
• Richie J.P., Jr., Lang C.A., Chen T.S. Acetaminophen-induced depletion of glutathione and cysteine in the aging mouse kidney. Biochemical Pharmacology 1992; 44: 129–135
   PubMedGoogle Scholar
• Usal A., Acarturk E., Yuregir G.T., Unlukurt I., Demirci C., Kurt H.I., Birand A. Decreased glutathione levels in acute myocardial infarction. Japanese Heart Journal 1996; 37: 177–182
   PubMedGoogle Scholar
• Dehmlow C., Erhard J., De Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 1996; 23: 749–754
   PubMed Web of Science ®Google Scholar
• Letteron P., Labbe G., Degott C., Berson A., Fromenty B., Delaforge M. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced peroxidation and hepatotoxicity in mice. Biochemical Pharmacology 1990; 39: 2027–2034
   PubMed Web of Science ®Google Scholar
• Comoglio A., Tomasi A., Malandrino S., Poli G., Albano E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochemical Pharmacology 1995; 50: 1313–1316
   PubMed Web of Science ®Google Scholar
• Pietrangelo A., Borella F., Casalgrandi G., Montosi G., Ceccarelli D., Gallesi D. Antioxidant activity of silybin in vivo during long-term iron-overload in rats. Gastroenterology 1995; 109: 1941–1949
   PubMed Web of Science ®Google Scholar
• Schuppan D., Lang T., Gerling G., Leng-Peschlow E., Krumbiegel G., Reicken E.O. Antifibrotic effect of silymarin in rat secondary biliary fibrosis induced by duct obliteration with ethibloc. Zeitschrift für Gastroenterologie 1994; 32: 45–46
   Google Scholar
• Boigk G., Stroedter L., Herbst H., Waldschmidt J., Riecken E.O., Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997; 26: 643–649
   PubMed Web of Science ®Google Scholar
• Saliou C., Rihn B., Cillard J., Okamoto T., Packer L. Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2 — Evidence for different activating pathways. FEBS Letters 1998; 440: 8–12
   PubMed Web of Science ®Google Scholar
• Bokemeyer C., Fels L.M., Dunn T., Voigt W., Gaedeke J., Schmoll H.J., Stolte H., Lentzen H. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. British Journal of Cancer 1996; 74: 2036–2041
   PubMed Web of Science ®Google Scholar
• Zima T., Kameníkova L., Janebová M., Buchar E., Crkovská J., Tesar V. The effect of silibinin on experimental cyclosporine nephrotoxicity. Renal Failure 1998; 20: 471–479
   PubMed Web of Science ®Google Scholar
• Dehmlow C., Murawski N., De Groot H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sciences 1996; 58: 1591–1600
   PubMed Web of Science ®Google Scholar
• Lorenz D., Lucker P.W., Mennicke W.H., Wetzelsberger N. Pharmacokinetic studies with silymarin in human serum and bile. Methods and Findings in Experimental and Clinical Pharmacology 1984; 6: 655–661
   PubMedGoogle Scholar
• Schandalik R., Gatti G., Perucca E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittelforschung 1992; 42: 964–968
   PubMed Web of Science ®Google Scholar
• Gatti G., Perucca E. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers. International Journal of Clinical Pharmacology 1994; 32: 614–617
   Google Scholar
• Hedley D.W., Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994; 15: 349–358
   PubMedGoogle Scholar
• Chikahisa L., Oyama Y., Okazaki E., Noda K. Fluorescent estimation of H2O2-induced changes in cell viability and cellular nonprotein thiol level of dissociated rat thymocytes. Japanese Journal of Pharmacology 1996; 71: 299–305
   PubMedGoogle Scholar
• Coates A., Tripp E. Comparison of two fluorochromes for flow cytometric assay of cellular glutathione content in human malignant melanoma. Melanoma Research 1995; 5: 107–111
   PubMed Web of Science ®Google Scholar
• Shany S., Rapoport J., Zuili I., Gavriel A., Lavi N., Chaimovitz C. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients. Kidney International 1991; 39: 1005–1011
   PubMedGoogle Scholar
• Kimmel P.L., Phillips T.M., Lew S.Q., Langman C.B. Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients. Kidney International 1996; 49: 1407–1412
   PubMedGoogle Scholar
• Lamperi S., Carozzi S., Nasini M.G. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD. Biomaterials, Artificial Cells, and Artificial Organs 1987; 15: 151–159
   PubMed Web of Science ®Google Scholar
• Lamperi S., Carozzi S. Immunological defenses in CAPD. Blood Purification 1989; 7: 126–143
   PubMed Web of Science ®Google Scholar
• Kain Z., Alkan M., Chaimovitz C., Segal S., Fridkin M., Levy R. Human peritoneal macrophage activity is increased by tuftsin. Immunological Letters 1989; 21: 257–261
   PubMedGoogle Scholar
• Levy R., Kain Z., Chaimovitz C., Fridkin M., Segal S., Alkan M. Potential use of tuftsin in treatment of candida peritonitis in a murine model. Journal of Biological Regulators and Homeostatic Agents 1989; 3: 71–78
   PubMedGoogle Scholar
• Wenzel S., Stolte H., Soose M. Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures. Journal of Pharmacology and Experimental Therapeutics 1996; 279: 1520–1526
   PubMed Web of Science ®Google Scholar
• Hamilos D.L., Wedner H.J. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. Journal of Immunology 1985; 135: 2740–2747
   PubMed Web of Science ®Google Scholar
• Elferink J.G.R., De Koster B.M. N-acetylcysteine causes a transient stimulation of neutrophil migration. Immunopharmacology 1998; 38: 229–236
   PubMedGoogle Scholar
• Del Rio M., Ruedas G., Medina S., Victor V.M., De la Fuente M. Improvement by several antioxidants of macrophage function in vitro. Life Sciences 1998; 63: 871–881
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione-ascorbic acid antioxidant system in animals. Journal of Biological Chemistry 1994; 269: 9397–9400
   PubMed Web of Science ®Google Scholar
• Martensson J., Meister A. Glutathione deficiency increases hepatic ascorbic acid synthesis in adult mice. Proceedings of the National Academy of Sciences U S A 1992; 89: 11566–11568
   PubMed Web of Science ®Google Scholar
• Meister A. Depletion of glutathione in normal and malignant human cells in vivo by L-buthionine sulfoximine: possible interaction with ascorbate. Journal of the National Cancer Institute 1992; 84: 1601–1602
   PubMed Web of Science ®Google Scholar